Valorisation-Recherche, Societe En commandite
7Patents
3Active
7Granted
33Portfolio score
Filing activity: Apr 27, 2000 → Mar 26, 2010 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8202847B2 | Mutant human CD80 and compositions for and methods of making and using the same | Human Necessities | 11 | Active |
| US7446189B1 | Nucleic acids encoding mutant human CD80 and compositions comprising the same | Human Necessities | 8 | Expired |
| US7445782B2 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases | Chemistry; Metallurgy | 6 | Expired |
| US7727531B2 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases | Chemistry; Metallurgy | 4 | Active |
| US8618054B2 | Interleukin-1 receptor antagonists, compositions, and methods of treatment | Human Necessities | 2 | Expired |
| US7785567B2 | Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia | Human Necessities | 1 | Expired |
| US8623372B2 | Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.